One of the cornerstones of TAG’s work is weighing in on mission-related issues by sending comment letters to a variety of organizations, including Federal agencies, Senate and House committees, Pharmaceutical companies, and the WHO. Various staff members also frequently testify in person at committee hearings, and submit written testimony.
2026 Letters
Letters Advocating for the Adoption of Near-Point-of-Care TB tests
July 27, 2026 — TAG and the Global TB CAB have a long history of advocating for the uptake of new health innovations, influencing global and national decision-making, and supporting policy translation. In March 2026, the World Health Organization (WHO) recommended a new class of tests — near point-of-care (NPOC) molecular tests — that offer faster, more decentralized, cheaper, and more accessible TB diagnosis
TAG Public Comments for the AIDS Research Advisory Council (ARAC) Meeting, April 6, 2026: Renewing Funding for the HIV Clinical Trial Networks
April 7, 2026 — TAG recommends that the AIDS Research Advisory Council (ARAC) endorse NIAID’s continued support of a balanced and comprehensive portfolio of basic, clinical, and implementation science — including a funding opportunity to renew its four current networks: the Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG), the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT), the HIV Prevention Trials Network (HPTN), and the HIV Vaccine Trials Network (HVTN) or the updated IBPTN.
